U.S. Food And Drug Administration

• Skip to main content
• Skip to FDA Search
• Skip to in this section menu
• Skip to footer links

Topic Paragraphs 1 Year of Reforms

• Fixing warnings on HRT
• Initiated national priority vouchers
• Accelerating biosimilars
• Boosting domestic manufacturing
• Modernizing infant formula
• Removing artificial food dyes
• Approving natural food dyes
• Unleashing cell & gene therapies
• Seizing illegal vapes
• Fixing opioid labels
• Cracking down on pharma ads
• Reducing animal testing
• Launching new dietary guidelines
• Revised Covid-19 vax framework
• Published FDA rejection letters
• Reviewing chemicals in food
• Closing GRAS loophole
• Launched FDA Direct Podcast
• Ending war on natural fats
• Hosted CEO listening tour
• Took action on 7-OH opioids
• Launched Elsa AI tool
• Defining ultra-processed foods
• Fixing orange juice regs
• Launched Agentic AI tool

And we're just getting started...

Featured Topics

Recalls Report a Problem Warning Letters Consumer Updates 483s EUAs 510Ks Guidance Documents Drug Databases

FDA in Action

FDA PreCheck Pilot Program Strengthens Domestic Pharmaceutical Manufacturing FDA Grant Two Petitions to Expand Food Color Options FDA ImportShield Program Delivers Impressive Results in Strengthening FDA Oversight at U.S. Ports of Entry

Press Announcements

February 10, 2026

FDA Launches Assessment of BHA, a Common Food Chemical Preservative

February 06, 2026

FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs

February 05, 2026

FDA Takes New Approach to "No Artificial Colors" Claims

Newsroom

Products We Regulate

Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood, and Biologics Animal and Veterinary Cosmetics Tobacco Products Back to Top Feedback